Trial Site Detail
Drug: |
Imatinib + Bevacizumab |
|||
|---|---|---|---|---|
Trial: |
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Terminated |
|||
Dayton Clinical Oncology Program - CCOP3525 Southern Boulevard |
Principal Investigator: |
Howard M Gross, MD |
|---|---|
Contact: |
937-395-8678 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Dayton Clinical Oncology Program - CCOP Website: |
http://www.med.wright.edu/dcop |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.